Use of adjuvant chemotherapy and outcomes in women age 70 and older with HER2-positive (HER2+) or triple-negative (TN) breast cancer (BC). This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results